CAMK2G and Cognitive impairment: In summary, these results indicate that the MDMA-caused lasting cognitive impairments in humans and experimental animals [2, 5, 8–10, 55, 56] may be partially consequences of transcriptional downregulations in essential elements of the CaMK II-mediated pathway in the HC at a chronic time point after use.